| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:3039.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction
From the Department of Internal Medicine/Division of Cardiology, School of Medicine, University of Texas-Houston Health Science Center (M.N., Z.B., S.S., S.N., M.M., W.C.), Houston, Tex, and Memorial Hermann Hospital and Texas Heart Institute/St. Luke’s Episcopal Hospital (W.C.), Houston, Tex.
Background—Numerous studies have suggested that microbial agents may promote atherosclerosis. A smaller body of research has suggested that acute respiratory infection may be a risk factor for myocardial infarction (MI). We hypothesized that influenza vaccine might reduce the risk of recurrent MI in patients with documented coronary heart disease (CHD).
Methods and Results—A case-control study was performed on 218 CHD patients seen at Memorial Hermann Hospital during the influenza season of October 1997 through March 1998. Patients who experienced new MI were included in the case group, and those who did not experience new MI or unstable angina were assigned to the control group. Data were collected by structured review of patients’ charts and through a subsequent telephone survey. Adjusted for history of influenza vaccination in previous years, multivariate logistic regression revealed risk of MI to be associated with current hypertension (OR 4.96, 95% CI 2.06 to 11.96, P<0.0001), hypercholesterolemia (OR 4.08, 95% CI 1.67 to 9.99, P=0.002), smoking (OR 3.75, 95% CI 1.76 to 7.98, P=0.001), and influenza vaccination (OR 0.33, 95% CI 0.13 to 0.82, P=0.017). Despite significant association in univariate analysis, multivitamin therapy and physical exercise were not associated with risk of reinfarction in multivariate analysis.
Conclusions—In this study in patients with chronic CHD, vaccination against influenza was negatively associated with the development of new MI during the same influenza season. However, to address causal inference, examination of prospective data sets will be needed.
Key Words: influenza vaccine • myocardial infarction • prevention • atherosclerosis • infection
This article has been cited by other articles:
 |
|
 |
|
  A. Ciszewski, Z. T. Bilinska, L. B. Brydak, C. Kepka, M. Kruk, M. Romanowska, E. Ksiezycka, J. Przyluski, W. Piotrowski, R. Maczynska, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study Eur. Heart J., June 1, 2008; 29(11): 1350 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Keller, J. J. van der Meer, P. Teeling, K. van der Sluijs, M. M. Idu, G. F. Rimmelzwaan, M. Levi, A. C. van der Wal, and O. J. de Boer Selective Expansion of Influenza A Virus-Specific T Cells in Symptomatic Human Carotid Artery Atherosclerotic Plaques Stroke, January 1, 2008; 39(1): 174 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Madjid, C. C. Miller, V. V. Zarubaev, I. G. Marinich, O. I. Kiselev, Y. V. Lobzin, A. E. Filippov, and S. W. Casscells III Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects Eur. Heart J., May 2, 2007; 28(10): 1205 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Davis, K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, and H. M. Krumholz Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1498 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Davis, K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, and H. M. Krumholz Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association.: The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory.: This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices. Circulation, October 3, 2006; 114(14): 1549 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Grau, B. Fischer, C. Barth, P. Ling, C. Lichy, and F. Buggle Influenza Vaccination Is Associated With a Reduced Risk of Stroke Stroke, July 1, 2005; 36(7): 1501 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hak, E. Buskens, G. A. van Essen, D. H. de Bakker, D. E. Grobbee, M. A. J. B. Tacken, B. A. van Hout, and T. J. M. Verheij Clinical Effectiveness of Influenza Vaccination in Persons Younger Than 65 Years With High-Risk Medical Conditions: The PRISMA Study Arch Intern Med, February 14, 2005; 165(3): 274 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nilsson, G. K. Hansson, and P. K. Shah Immunomodulation of Atherosclerosis: Implications for Vaccine Development Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 18 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Reichert, L. Simonsen, A. Sharma, S. A. Pardo, D. S. Fedson, and M. A. Miller Influenza and the Winter Increase in Mortality in the United States, 1959-1999 Am. J. Epidemiol., September 1, 2004; 160(5): 492 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. de Roux, M. A. Marcos, E. Garcia, J. Mensa, S. Ewig, H. Lode, and A. Torres Viral Community-Acquired Pneumonia in Nonimmunocompromised Adults Chest, April 1, 2004; 125(4): 1343 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Gurfinkel, R. Leon de la Fuente, O. Mendiz, and B. Mautner Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study: One-year follow-up Eur. Heart J., January 1, 2004; 25(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Madjid, M. Naghavi, S. Litovsky, and S. W. Casscells Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies Circulation, December 2, 2003; 108(22): 2730 - 2736. [Full Text] [PDF]
|
|
|
|
|
|
L. Kaiser, C. Wat, T. Mills, P. Mahoney, P. Ward, and F. Hayden Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations Arch Intern Med, July 28, 2003; 163(14): 1667 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sorokin, M. Charlson, and O. W. Isom Care after Coronary-Artery Bypass Surgery N. Engl. J. Med., July 17, 2003; 349(3): 307 - 307. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Madjid, S. Lillibridge, P. Mirhaji, and W. Casscells Influenza as a bioweapon J R Soc Med, July 1, 2003; 96(7): 345 - 346. [Full Text] [PDF]
|
|
|
|
|
|
K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly N. Engl. J. Med., April 3, 2003; 348(14): 1322 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Naghavi, P. Wyde, S. Litovsky, M. Madjid, A. Akhtar, S. Naguib, M. S. Siadaty, S. Sanati, and W. Casscells Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E-Deficient Mice Circulation, February 11, 2003; 107(5): 762 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paldanius, A. Bloigu, M. Leinonen, and P. Saikku Measurement of Chlamydia pneumoniae-Specific Immunoglobulin A (IgA) Antibodies by the Microimmunofluorescence (MIF) Method: Comparison of Seven Fluorescein-Labeled Anti-Human IgA Conjugates in an In-House MIF Test Using One Commercial MIF and One Enzyme Immunoassay Kit Clin. Vaccine Immunol., January 1, 2003; 10(1): 8 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jackson, O. Yu, S. R. Heckbert, B. M. Psaty, D. Malais, W. E. Barlow, and W. W. Thompson Influenza Vaccination Is Not Associated with a Reduction in the Risk of Recurrent Coronary Events Am. J. Epidemiol., October 1, 2002; 156(7): 634 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. McElhaney Guest Editorial: Influenza: A Preventable Lethal Disease J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M627 - 628. [Full Text] [PDF]
|
|
|
|
 |
|
 I. W. FONG Infections and their role in atherosclerotic vascular disease J Am Dent Assoc, June 1, 2002; 133(suppl_1): 7S - 13S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stollberger and J. Finsterer Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis Clin. Vaccine Immunol., March 1, 2002; 9(2): 207 - 215. [Full Text] [PDF]
|
|
|
|
|
|
P. Lavallee, V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco Association Between Influenza Vaccination and Reduced Risk of Brain Infarction Stroke, February 1, 2002; 33(2): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Flu Vaccine Associated with Lower Risk for Recurrent MI Journal Watch Cardiology, February 16, 2001; 2001(216): 12 - 12. [Full Text]
|
|
|
|
 |
|
 Flu Vaccine Associated with Lower Risk for Recurrent MI Journal Watch (General), January 12, 2001; 2001(112): 2 - 2. [Full Text]
|
|
|
|
|
|
E. P. Gurfinkel, R. L. de la Fuente, O. Mendiz, B. Mautner, and for the FLUVACS Study Group Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study Circulation, May 7, 2002; 105(18): 2143 - 2147. [Abstract] [Full Text] [PDF]
|
|